World / Science & Health Sep 11, 2020
Some scientists hope a vaccine that gets sprayed through the nose may have a better chance of stopping the spread of the insidious virus through respiratory tracts.
Some scientists hope a vaccine that gets sprayed through the nose may have a better chance of stopping the spread of the insidious virus through respiratory tracts.
Vaccine politics demand more from big pharma
The FDA usually wants high standards while drugmakers push boundaries. But political pressure and public unease over a rushed process has forced a role reversal.
The pandemic has prompted one of the fastest peacetime mission shifts in recent times for the world’s intelligence agencies, pitting them against one another.
COVID-19 vaccine front-runners will soon see their moment of truth
Early safety data is key; unlike drugs, vaccines are typically given to relatively healthy people and shouldn’t create severe risks.
One of the world’s fastest-moving efforts to develop a COVID-19 vaccine is falling behind rivals, its advance appearing to be stymied by political tensions between China and Canada and concerns its shot may not work as well as others. CanSino Biologics Inc., the Chinese company ...
Japan to join international framework to procure coronavirus vaccine
The government will consider financially supporting the development of nine potential vaccines that are currently in the second to third stages of clinical trials.
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say. CanSino Biologics' vaccine, approved for military use in China, is a ...
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development. The vaccine, known as DS-5670, was picked for the second round of AMED's program dedicated ...
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years. For the drugmaker, the sale could represent one of the last ...
Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion
Takeda is aiming to reduce debts after its purchase of Irish drugmaker Shire in January last year, the largest-ever Japanese acquisition of a foreign company.
Philippines begins nine-month clinical trial on Avigan in COVID-19 study
The Philippines started nine-month clinical trials for Avigan on Monday to study the efficacy of the Japanese anti-flu drug against the disease caused by the new coronavirus. Health Undersecretary Maria Rosario Vergeire said the clinical trials will include just four hospitals in Metro Manila initially ...